Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Journal: Blood advances
Published: April 15, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Journal: Blood advances
Published: April 15, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Journal: Blood advances
Published: April 15, 2025
Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.
Journal: Advanced drug delivery reviews
Published: February 17, 2022
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma.
Journal: Leukemia & lymphoma
Published: September 16, 2020
Adoptive T cell therapy: Boosting the immune system to fight cancer.
Journal: Seminars in immunology
Published: August 12, 2020
CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 30, 2020
Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 05, 2015
Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 13, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026